Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study

Since it was first described in December 2019, more than seventy thousand cases of Corona Virus Disease 2019 (COVID-19) have been confirmed, beyond two thousand patients of which were fatal.1 –4 So far, the infection keeps spreading, and more and more exported cases were confirmed in other provinces in China, and other countries. Indicating that the disease is a serious threat to global health.5,6 The management of patients with COVID-19 consists of a combination of supportive measures , antimicrobial therapy for any associated bacterial or viral infections, and strict implementation of appropriate infection control precautions.
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: Review Source Type: research